Interestingly, more than 91% of TP53-mutant cancers exhibit second allele loss by various molecular mechanisms (mutation, chromosomal deletion, or copy-neutral loss of heterozygosity); furthermore, most of TP53-mutated cancers display enhanced chromosomal instability [325]. This evidence concerns the gene TP53 and cancer.